nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP3A4—type 2 diabetes mellitus	0.119	1	CbGaD
Eletriptan—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0395	0.0664	CbGbCtD
Eletriptan—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0316	0.0531	CbGbCtD
Eletriptan—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0309	0.052	CbGbCtD
Eletriptan—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0303	0.0509	CbGbCtD
Eletriptan—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0258	0.0433	CbGbCtD
Eletriptan—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0239	0.0401	CbGbCtD
Eletriptan—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0239	0.0401	CbGbCtD
Eletriptan—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.022	0.037	CbGbCtD
Eletriptan—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.019	0.0319	CbGbCtD
Eletriptan—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0181	0.0304	CbGbCtD
Eletriptan—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0173	0.0291	CbGbCtD
Eletriptan—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0145	0.0243	CbGbCtD
Eletriptan—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0136	0.0228	CbGbCtD
Eletriptan—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0133	0.0223	CbGbCtD
Eletriptan—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0129	0.0217	CbGbCtD
Eletriptan—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0122	0.0204	CbGbCtD
Eletriptan—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0116	0.0194	CbGbCtD
Eletriptan—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0116	0.0194	CbGbCtD
Eletriptan—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0113	0.019	CbGbCtD
Eletriptan—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0107	0.0179	CbGbCtD
Eletriptan—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0103	0.0173	CbGbCtD
Eletriptan—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0096	0.0161	CbGbCtD
Eletriptan—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0096	0.0161	CbGbCtD
Eletriptan—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00932	0.0157	CbGbCtD
Eletriptan—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00886	0.0149	CbGbCtD
Eletriptan—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00878	0.0148	CbGbCtD
Eletriptan—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00867	0.0146	CbGbCtD
Eletriptan—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00856	0.0144	CbGbCtD
Eletriptan—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00811	0.0136	CbGbCtD
Eletriptan—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00783	0.0132	CbGbCtD
Eletriptan—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00772	0.013	CbGbCtD
Eletriptan—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00728	0.0122	CbGbCtD
Eletriptan—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00706	0.0119	CbGbCtD
Eletriptan—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00698	0.0117	CbGbCtD
Eletriptan—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00666	0.0112	CbGbCtD
Eletriptan—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0064	0.0108	CbGbCtD
Eletriptan—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00638	0.0107	CbGbCtD
Eletriptan—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00618	0.0104	CbGbCtD
Eletriptan—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00591	0.00994	CbGbCtD
Eletriptan—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00558	0.00939	CbGbCtD
Eletriptan—CYP2C19—Losartan—type 2 diabetes mellitus	0.00541	0.00909	CbGbCtD
Eletriptan—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00492	0.00826	CbGbCtD
Eletriptan—ABCB1—Glyburide—type 2 diabetes mellitus	0.00477	0.00802	CbGbCtD
Eletriptan—CYP2C9—Losartan—type 2 diabetes mellitus	0.0045	0.00756	CbGbCtD
Eletriptan—ABCB1—Losartan—type 2 diabetes mellitus	0.00436	0.00733	CbGbCtD
Eletriptan—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00423	0.00711	CbGbCtD
Eletriptan—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00406	0.00682	CbGbCtD
Eletriptan—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00406	0.00682	CbGbCtD
Eletriptan—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00384	0.00645	CbGbCtD
Eletriptan—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00286	0.0048	CbGbCtD
Eletriptan—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00266	0.131	CbGeAlD
Eletriptan—CYP3A4—Losartan—type 2 diabetes mellitus	0.00261	0.00439	CbGbCtD
Eletriptan—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00179	0.0878	CbGeAlD
Eletriptan—HTR1B—artery—type 2 diabetes mellitus	0.00132	0.0645	CbGeAlD
Eletriptan—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00129	0.0633	CbGeAlD
Eletriptan—HTR1D—artery—type 2 diabetes mellitus	0.00127	0.0625	CbGeAlD
Eletriptan—HTR7—artery—type 2 diabetes mellitus	0.00101	0.0498	CbGeAlD
Eletriptan—HTR7—nerve—type 2 diabetes mellitus	0.00101	0.0494	CbGeAlD
Eletriptan—HTR7—endothelium—type 2 diabetes mellitus	0.000857	0.042	CbGeAlD
Eletriptan—PTGS1—artery—type 2 diabetes mellitus	0.000701	0.0344	CbGeAlD
Eletriptan—PTGS1—endothelium—type 2 diabetes mellitus	0.000592	0.0291	CbGeAlD
Eletriptan—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000472	0.0232	CbGeAlD
Eletriptan—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000457	0.0224	CbGeAlD
Eletriptan—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000443	0.0217	CbGeAlD
Eletriptan—HTR1D—kidney—type 2 diabetes mellitus	0.000433	0.0212	CbGeAlD
Eletriptan—Zolmitriptan—CYP1A2—type 2 diabetes mellitus	0.00042	0.179	CrCbGaD
Eletriptan—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000412	0.0202	CbGeAlD
Eletriptan—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000392	0.0192	CbGeAlD
Eletriptan—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000369	0.0181	CbGeAlD
Eletriptan—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000363	0.0178	CbGeAlD
Eletriptan—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000353	0.0173	CbGeAlD
Eletriptan—HTR7—kidney—type 2 diabetes mellitus	0.000345	0.0169	CbGeAlD
Eletriptan—Almotriptan—CYP2E1—type 2 diabetes mellitus	0.000335	0.143	CrCbGaD
Eletriptan—CYP2A6—liver—type 2 diabetes mellitus	0.000331	0.0162	CbGeAlD
Eletriptan—Almotriptan—CYP1A2—type 2 diabetes mellitus	0.000318	0.136	CrCbGaD
Eletriptan—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000267	0.0131	CbGeAlD
Eletriptan—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000244	0.012	CbGeAlD
Eletriptan—Clemastine—CYP3A4—type 2 diabetes mellitus	0.000243	0.104	CrCbGaD
Eletriptan—PTGS1—kidney—type 2 diabetes mellitus	0.000238	0.0117	CbGeAlD
Eletriptan—Mesoridazine—HTR2C—type 2 diabetes mellitus	0.000219	0.0933	CrCbGaD
Eletriptan—HTR7—liver—type 2 diabetes mellitus	0.000218	0.0107	CbGeAlD
Eletriptan—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000215	0.0105	CbGeAlD
Eletriptan—CYP2C19—liver—type 2 diabetes mellitus	0.000213	0.0104	CbGeAlD
Eletriptan—Almotriptan—CYP3A4—type 2 diabetes mellitus	0.000211	0.0899	CrCbGaD
Eletriptan—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000199	0.00977	CbGeAlD
Eletriptan—CYP3A4—kidney—type 2 diabetes mellitus	0.000199	0.00977	CbGeAlD
Eletriptan—CYP2D6—kidney—type 2 diabetes mellitus	0.000196	0.00961	CbGeAlD
Eletriptan—Thioridazine—ADRA2A—type 2 diabetes mellitus	0.000179	0.0764	CrCbGaD
Eletriptan—ABCB1—retina—type 2 diabetes mellitus	0.00017	0.00835	CbGeAlD
Eletriptan—CYP2C9—liver—type 2 diabetes mellitus	0.000165	0.0081	CbGeAlD
Eletriptan—Thioridazine—HTR2C—type 2 diabetes mellitus	0.000165	0.0704	CrCbGaD
Eletriptan—ABCB1—nephron tubule—type 2 diabetes mellitus	0.00016	0.00787	CbGeAlD
Eletriptan—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000144	0.00707	CbGeAlD
Eletriptan—ABCB1—kidney—type 2 diabetes mellitus	0.000141	0.00691	CbGeAlD
Eletriptan—ABCB1—pancreas—type 2 diabetes mellitus	0.00014	0.00687	CbGeAlD
Eletriptan—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000137	0.00673	CbGeAlD
Eletriptan—Thioridazine—CYP2E1—type 2 diabetes mellitus	0.000131	0.0558	CrCbGaD
Eletriptan—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000127	0.00623	CbGeAlD
Eletriptan—CYP3A4—liver—type 2 diabetes mellitus	0.000126	0.00617	CbGeAlD
Eletriptan—Thioridazine—CYP1A2—type 2 diabetes mellitus	0.000125	0.0531	CrCbGaD
Eletriptan—CYP2D6—liver—type 2 diabetes mellitus	0.000124	0.00608	CbGeAlD
Eletriptan—ABCB1—liver—type 2 diabetes mellitus	8.91e-05	0.00437	CbGeAlD
Eletriptan—Flushing—Ramipril—type 2 diabetes mellitus	7.8e-05	0.00046	CcSEcCtD
Eletriptan—Angioedema—Losartan—type 2 diabetes mellitus	7.79e-05	0.00046	CcSEcCtD
Eletriptan—Insomnia—Valsartan—type 2 diabetes mellitus	7.79e-05	0.000459	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.75e-05	0.000457	CcSEcCtD
Eletriptan—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.73e-05	0.000456	CcSEcCtD
Eletriptan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.72e-05	0.000455	CcSEcCtD
Eletriptan—Myalgia—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000455	CcSEcCtD
Eletriptan—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000455	CcSEcCtD
Eletriptan—Shock—Metformin—type 2 diabetes mellitus	7.71e-05	0.000455	CcSEcCtD
Eletriptan—Insomnia—Orlistat—type 2 diabetes mellitus	7.69e-05	0.000454	CcSEcCtD
Eletriptan—Malaise—Losartan—type 2 diabetes mellitus	7.69e-05	0.000454	CcSEcCtD
Eletriptan—Anxiety—Irbesartan—type 2 diabetes mellitus	7.69e-05	0.000453	CcSEcCtD
Eletriptan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.69e-05	0.000453	CcSEcCtD
Eletriptan—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.69e-05	0.000453	CcSEcCtD
Eletriptan—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.67e-05	0.000452	CcSEcCtD
Eletriptan—Vertigo—Losartan—type 2 diabetes mellitus	7.66e-05	0.000452	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.66e-05	0.000452	CcSEcCtD
Eletriptan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.66e-05	0.000452	CcSEcCtD
Eletriptan—Somnolence—Valsartan—type 2 diabetes mellitus	7.65e-05	0.000451	CcSEcCtD
Eletriptan—Syncope—Losartan—type 2 diabetes mellitus	7.65e-05	0.000451	CcSEcCtD
Eletriptan—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.64e-05	0.00045	CcSEcCtD
Eletriptan—Leukopenia—Losartan—type 2 diabetes mellitus	7.64e-05	0.00045	CcSEcCtD
Eletriptan—Discomfort—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.00045	CcSEcCtD
Eletriptan—Skin disorder—Metformin—type 2 diabetes mellitus	7.61e-05	0.000449	CcSEcCtD
Eletriptan—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000447	CcSEcCtD
Eletriptan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.58e-05	0.000447	CcSEcCtD
Eletriptan—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.58e-05	0.000447	CcSEcCtD
Eletriptan—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.55e-05	0.000445	CcSEcCtD
Eletriptan—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000445	CcSEcCtD
Eletriptan—Palpitations—Losartan—type 2 diabetes mellitus	7.54e-05	0.000444	CcSEcCtD
Eletriptan—Nausea—Glimepiride—type 2 diabetes mellitus	7.51e-05	0.000443	CcSEcCtD
Eletriptan—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.51e-05	0.000443	CcSEcCtD
Eletriptan—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.5e-05	0.000442	CcSEcCtD
Eletriptan—Nausea—Sitagliptin—type 2 diabetes mellitus	7.49e-05	0.000442	CcSEcCtD
Eletriptan—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.49e-05	0.000441	CcSEcCtD
Eletriptan—Asthenia—Glyburide—type 2 diabetes mellitus	7.49e-05	0.000441	CcSEcCtD
Eletriptan—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.48e-05	0.000441	CcSEcCtD
Eletriptan—Anorexia—Metformin—type 2 diabetes mellitus	7.47e-05	0.000441	CcSEcCtD
Eletriptan—Cough—Losartan—type 2 diabetes mellitus	7.44e-05	0.000439	CcSEcCtD
Eletriptan—Urticaria—Gliclazide—type 2 diabetes mellitus	7.44e-05	0.000439	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.43e-05	0.000438	CcSEcCtD
Eletriptan—Alopecia—Ramipril—type 2 diabetes mellitus	7.42e-05	0.000438	CcSEcCtD
Eletriptan—Fatigue—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000438	CcSEcCtD
Eletriptan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.41e-05	0.000437	CcSEcCtD
Eletriptan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.41e-05	0.000437	CcSEcCtD
Eletriptan—Oedema—Irbesartan—type 2 diabetes mellitus	7.4e-05	0.000436	CcSEcCtD
Eletriptan—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.39e-05	0.000436	CcSEcCtD
Eletriptan—Pruritus—Glyburide—type 2 diabetes mellitus	7.38e-05	0.000435	CcSEcCtD
Eletriptan—Constipation—Valsartan—type 2 diabetes mellitus	7.36e-05	0.000434	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.34e-05	0.000433	CcSEcCtD
Eletriptan—Fatigue—Orlistat—type 2 diabetes mellitus	7.33e-05	0.000432	CcSEcCtD
Eletriptan—Hypotension—Metformin—type 2 diabetes mellitus	7.32e-05	0.000432	CcSEcCtD
Eletriptan—Shock—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000429	CcSEcCtD
Eletriptan—Pain—Orlistat—type 2 diabetes mellitus	7.27e-05	0.000429	CcSEcCtD
Eletriptan—Arthralgia—Losartan—type 2 diabetes mellitus	7.26e-05	0.000428	CcSEcCtD
Eletriptan—Myalgia—Losartan—type 2 diabetes mellitus	7.26e-05	0.000428	CcSEcCtD
Eletriptan—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.26e-05	0.000428	CcSEcCtD
Eletriptan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.25e-05	0.000428	CcSEcCtD
Eletriptan—Anxiety—Losartan—type 2 diabetes mellitus	7.24e-05	0.000427	CcSEcCtD
Eletriptan—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000426	CcSEcCtD
Eletriptan—Rash—Bromocriptine—type 2 diabetes mellitus	7.2e-05	0.000424	CcSEcCtD
Eletriptan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.19e-05	0.000424	CcSEcCtD
Eletriptan—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.18e-05	0.000424	CcSEcCtD
Eletriptan—Tension—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000423	CcSEcCtD
Eletriptan—Discomfort—Losartan—type 2 diabetes mellitus	7.17e-05	0.000423	CcSEcCtD
Eletriptan—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000422	CcSEcCtD
Eletriptan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000422	CcSEcCtD
Eletriptan—Headache—Bromocriptine—type 2 diabetes mellitus	7.15e-05	0.000422	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.14e-05	0.000421	CcSEcCtD
Eletriptan—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.14e-05	0.000421	CcSEcCtD
Eletriptan—Nervousness—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000419	CcSEcCtD
Eletriptan—Dry mouth—Losartan—type 2 diabetes mellitus	7.1e-05	0.000419	CcSEcCtD
Eletriptan—Anorexia—Irbesartan—type 2 diabetes mellitus	7.05e-05	0.000416	CcSEcCtD
Eletriptan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.04e-05	0.000415	CcSEcCtD
Eletriptan—Paraesthesia—Metformin—type 2 diabetes mellitus	7.04e-05	0.000415	CcSEcCtD
Eletriptan—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000415	CcSEcCtD
Eletriptan—Confusional state—Losartan—type 2 diabetes mellitus	7.02e-05	0.000414	CcSEcCtD
Eletriptan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.01e-05	0.000413	CcSEcCtD
Eletriptan—Dyspnoea—Metformin—type 2 diabetes mellitus	6.99e-05	0.000412	CcSEcCtD
Eletriptan—Somnolence—Metformin—type 2 diabetes mellitus	6.97e-05	0.000411	CcSEcCtD
Eletriptan—Oedema—Losartan—type 2 diabetes mellitus	6.96e-05	0.00041	CcSEcCtD
Eletriptan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.95e-05	0.00041	CcSEcCtD
Eletriptan—Hypotension—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.000408	CcSEcCtD
Eletriptan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.9e-05	0.000407	CcSEcCtD
Eletriptan—Dyspepsia—Metformin—type 2 diabetes mellitus	6.9e-05	0.000407	CcSEcCtD
Eletriptan—Tremor—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000404	CcSEcCtD
Eletriptan—Shock—Losartan—type 2 diabetes mellitus	6.85e-05	0.000404	CcSEcCtD
Eletriptan—Urticaria—Valsartan—type 2 diabetes mellitus	6.84e-05	0.000403	CcSEcCtD
Eletriptan—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.83e-05	0.000403	CcSEcCtD
Eletriptan—Decreased appetite—Metformin—type 2 diabetes mellitus	6.81e-05	0.000402	CcSEcCtD
Eletriptan—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.8e-05	0.000401	CcSEcCtD
Eletriptan—Tachycardia—Losartan—type 2 diabetes mellitus	6.79e-05	0.000401	CcSEcCtD
Eletriptan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.79e-05	0.0004	CcSEcCtD
Eletriptan—Nausea—Bromocriptine—type 2 diabetes mellitus	6.78e-05	0.0004	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.77e-05	0.000399	CcSEcCtD
Eletriptan—Fatigue—Metformin—type 2 diabetes mellitus	6.76e-05	0.000398	CcSEcCtD
Eletriptan—Urticaria—Orlistat—type 2 diabetes mellitus	6.76e-05	0.000398	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000397	CcSEcCtD
Eletriptan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.73e-05	0.000397	CcSEcCtD
Eletriptan—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.72e-05	0.000396	CcSEcCtD
Eletriptan—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.72e-05	0.000396	CcSEcCtD
Eletriptan—Asthenia—Gliclazide—type 2 diabetes mellitus	6.72e-05	0.000396	CcSEcCtD
Eletriptan—Agitation—Ramipril—type 2 diabetes mellitus	6.72e-05	0.000396	CcSEcCtD
Eletriptan—Constipation—Metformin—type 2 diabetes mellitus	6.7e-05	0.000395	CcSEcCtD
Eletriptan—Angioedema—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000394	CcSEcCtD
Eletriptan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000392	CcSEcCtD
Eletriptan—Anorexia—Losartan—type 2 diabetes mellitus	6.64e-05	0.000391	CcSEcCtD
Eletriptan—Vomiting—Glyburide—type 2 diabetes mellitus	6.63e-05	0.000391	CcSEcCtD
Eletriptan—Pruritus—Gliclazide—type 2 diabetes mellitus	6.63e-05	0.000391	CcSEcCtD
Eletriptan—Malaise—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000389	CcSEcCtD
Eletriptan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.59e-05	0.000389	CcSEcCtD
Eletriptan—Rash—Glyburide—type 2 diabetes mellitus	6.58e-05	0.000388	CcSEcCtD
Eletriptan—Somnolence—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000388	CcSEcCtD
Eletriptan—Dermatitis—Glyburide—type 2 diabetes mellitus	6.57e-05	0.000388	CcSEcCtD
Eletriptan—Vertigo—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000387	CcSEcCtD
Eletriptan—Syncope—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000387	CcSEcCtD
Eletriptan—Leukopenia—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000386	CcSEcCtD
Eletriptan—Headache—Glyburide—type 2 diabetes mellitus	6.54e-05	0.000385	CcSEcCtD
Eletriptan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.51e-05	0.000384	CcSEcCtD
Eletriptan—Hypotension—Losartan—type 2 diabetes mellitus	6.5e-05	0.000384	CcSEcCtD
Eletriptan—Palpitations—Ramipril—type 2 diabetes mellitus	6.46e-05	0.000381	CcSEcCtD
Eletriptan—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.46e-05	0.000381	CcSEcCtD
Eletriptan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000379	CcSEcCtD
Eletriptan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000379	CcSEcCtD
Eletriptan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.41e-05	0.000378	CcSEcCtD
Eletriptan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.41e-05	0.000378	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000377	CcSEcCtD
Eletriptan—Cough—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000376	CcSEcCtD
Eletriptan—Fatigue—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000376	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.34e-05	0.000374	CcSEcCtD
Eletriptan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.34e-05	0.000374	CcSEcCtD
Eletriptan—Convulsion—Ramipril—type 2 diabetes mellitus	6.34e-05	0.000374	CcSEcCtD
Eletriptan—Pain—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.000373	CcSEcCtD
Eletriptan—Constipation—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.000373	CcSEcCtD
Eletriptan—Insomnia—Losartan—type 2 diabetes mellitus	6.3e-05	0.000371	CcSEcCtD
Eletriptan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.27e-05	0.000369	CcSEcCtD
Eletriptan—Paraesthesia—Losartan—type 2 diabetes mellitus	6.25e-05	0.000369	CcSEcCtD
Eletriptan—Urticaria—Metformin—type 2 diabetes mellitus	6.23e-05	0.000367	CcSEcCtD
Eletriptan—Myalgia—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000367	CcSEcCtD
Eletriptan—Arthralgia—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000367	CcSEcCtD
Eletriptan—Dyspnoea—Losartan—type 2 diabetes mellitus	6.21e-05	0.000366	CcSEcCtD
Eletriptan—Anxiety—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000366	CcSEcCtD
Eletriptan—Nausea—Glyburide—type 2 diabetes mellitus	6.2e-05	0.000365	CcSEcCtD
Eletriptan—Abdominal pain—Metformin—type 2 diabetes mellitus	6.2e-05	0.000365	CcSEcCtD
Eletriptan—Dizziness—Gliclazide—type 2 diabetes mellitus	6.2e-05	0.000365	CcSEcCtD
Eletriptan—Somnolence—Losartan—type 2 diabetes mellitus	6.19e-05	0.000365	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.18e-05	0.000365	CcSEcCtD
Eletriptan—Asthenia—Valsartan—type 2 diabetes mellitus	6.18e-05	0.000364	CcSEcCtD
Eletriptan—Discomfort—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000363	CcSEcCtD
Eletriptan—Dyspepsia—Losartan—type 2 diabetes mellitus	6.13e-05	0.000361	CcSEcCtD
Eletriptan—Asthenia—Orlistat—type 2 diabetes mellitus	6.1e-05	0.00036	CcSEcCtD
Eletriptan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.1e-05	0.000359	CcSEcCtD
Eletriptan—Pruritus—Valsartan—type 2 diabetes mellitus	6.09e-05	0.000359	CcSEcCtD
Eletriptan—Dry mouth—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000359	CcSEcCtD
Eletriptan—Decreased appetite—Losartan—type 2 diabetes mellitus	6.05e-05	0.000357	CcSEcCtD
Eletriptan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.05e-05	0.000357	CcSEcCtD
Eletriptan—Confusional state—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000355	CcSEcCtD
Eletriptan—Pruritus—Orlistat—type 2 diabetes mellitus	6.02e-05	0.000355	CcSEcCtD
Eletriptan—Fatigue—Losartan—type 2 diabetes mellitus	6e-05	0.000354	CcSEcCtD
Eletriptan—Oedema—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000352	CcSEcCtD
Eletriptan—Vomiting—Gliclazide—type 2 diabetes mellitus	5.96e-05	0.000351	CcSEcCtD
Eletriptan—Pain—Losartan—type 2 diabetes mellitus	5.95e-05	0.000351	CcSEcCtD
Eletriptan—Constipation—Losartan—type 2 diabetes mellitus	5.95e-05	0.000351	CcSEcCtD
Eletriptan—Rash—Gliclazide—type 2 diabetes mellitus	5.91e-05	0.000348	CcSEcCtD
Eletriptan—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.9e-05	0.000348	CcSEcCtD
Eletriptan—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.89e-05	0.000347	CcSEcCtD
Eletriptan—Urticaria—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.000346	CcSEcCtD
Eletriptan—Shock—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000346	CcSEcCtD
Eletriptan—Headache—Gliclazide—type 2 diabetes mellitus	5.87e-05	0.000346	CcSEcCtD
Eletriptan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000345	CcSEcCtD
Eletriptan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.85e-05	0.000345	CcSEcCtD
Eletriptan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.85e-05	0.000345	CcSEcCtD
Eletriptan—Tachycardia—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000344	CcSEcCtD
Eletriptan—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.82e-05	0.000343	CcSEcCtD
Eletriptan—Skin disorder—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000342	CcSEcCtD
Eletriptan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.77e-05	0.00034	CcSEcCtD
Eletriptan—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.74e-05	0.000338	CcSEcCtD
Eletriptan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.69e-05	0.000336	CcSEcCtD
Eletriptan—Dizziness—Valsartan—type 2 diabetes mellitus	5.69e-05	0.000336	CcSEcCtD
Eletriptan—Anorexia—Ramipril—type 2 diabetes mellitus	5.69e-05	0.000335	CcSEcCtD
Eletriptan—Dizziness—Orlistat—type 2 diabetes mellitus	5.62e-05	0.000332	CcSEcCtD
Eletriptan—Asthenia—Metformin—type 2 diabetes mellitus	5.62e-05	0.000332	CcSEcCtD
Eletriptan—Hypotension—Ramipril—type 2 diabetes mellitus	5.58e-05	0.000329	CcSEcCtD
Eletriptan—Nausea—Gliclazide—type 2 diabetes mellitus	5.56e-05	0.000328	CcSEcCtD
Eletriptan—Pruritus—Metformin—type 2 diabetes mellitus	5.55e-05	0.000327	CcSEcCtD
Eletriptan—Urticaria—Losartan—type 2 diabetes mellitus	5.53e-05	0.000326	CcSEcCtD
Eletriptan—Abdominal pain—Losartan—type 2 diabetes mellitus	5.5e-05	0.000324	CcSEcCtD
Eletriptan—Body temperature increased—Losartan—type 2 diabetes mellitus	5.5e-05	0.000324	CcSEcCtD
Eletriptan—Vomiting—Valsartan—type 2 diabetes mellitus	5.47e-05	0.000323	CcSEcCtD
Eletriptan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.45e-05	0.000321	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000321	CcSEcCtD
Eletriptan—Rash—Valsartan—type 2 diabetes mellitus	5.43e-05	0.00032	CcSEcCtD
Eletriptan—Dermatitis—Valsartan—type 2 diabetes mellitus	5.42e-05	0.00032	CcSEcCtD
Eletriptan—Vomiting—Orlistat—type 2 diabetes mellitus	5.41e-05	0.000319	CcSEcCtD
Eletriptan—Insomnia—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000318	CcSEcCtD
Eletriptan—Headache—Valsartan—type 2 diabetes mellitus	5.39e-05	0.000318	CcSEcCtD
Eletriptan—Diarrhoea—Metformin—type 2 diabetes mellitus	5.36e-05	0.000316	CcSEcCtD
Eletriptan—Rash—Orlistat—type 2 diabetes mellitus	5.36e-05	0.000316	CcSEcCtD
Eletriptan—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000316	CcSEcCtD
Eletriptan—Dermatitis—Orlistat—type 2 diabetes mellitus	5.36e-05	0.000316	CcSEcCtD
Eletriptan—Headache—Orlistat—type 2 diabetes mellitus	5.33e-05	0.000314	CcSEcCtD
Eletriptan—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000314	CcSEcCtD
Eletriptan—Asthenia—Irbesartan—type 2 diabetes mellitus	5.31e-05	0.000313	CcSEcCtD
Eletriptan—Somnolence—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000313	CcSEcCtD
Eletriptan—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.25e-05	0.00031	CcSEcCtD
Eletriptan—Pruritus—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000309	CcSEcCtD
Eletriptan—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000306	CcSEcCtD
Eletriptan—Dizziness—Metformin—type 2 diabetes mellitus	5.18e-05	0.000306	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000304	CcSEcCtD
Eletriptan—Fatigue—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000303	CcSEcCtD
Eletriptan—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.13e-05	0.000302	CcSEcCtD
Eletriptan—Nausea—Valsartan—type 2 diabetes mellitus	5.11e-05	0.000301	CcSEcCtD
Eletriptan—Constipation—Ramipril—type 2 diabetes mellitus	5.1e-05	0.000301	CcSEcCtD
Eletriptan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000298	CcSEcCtD
Eletriptan—Nausea—Orlistat—type 2 diabetes mellitus	5.05e-05	0.000298	CcSEcCtD
Eletriptan—Asthenia—Losartan—type 2 diabetes mellitus	4.99e-05	0.000294	CcSEcCtD
Eletriptan—Vomiting—Metformin—type 2 diabetes mellitus	4.98e-05	0.000294	CcSEcCtD
Eletriptan—Rash—Metformin—type 2 diabetes mellitus	4.94e-05	0.000291	CcSEcCtD
Eletriptan—Dermatitis—Metformin—type 2 diabetes mellitus	4.94e-05	0.000291	CcSEcCtD
Eletriptan—Pruritus—Losartan—type 2 diabetes mellitus	4.93e-05	0.00029	CcSEcCtD
Eletriptan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.92e-05	0.00029	CcSEcCtD
Eletriptan—Headache—Metformin—type 2 diabetes mellitus	4.91e-05	0.00029	CcSEcCtD
Eletriptan—Dizziness—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000288	CcSEcCtD
Eletriptan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000288	CcSEcCtD
Eletriptan—Diarrhoea—Losartan—type 2 diabetes mellitus	4.76e-05	0.000281	CcSEcCtD
Eletriptan—Urticaria—Ramipril—type 2 diabetes mellitus	4.74e-05	0.00028	CcSEcCtD
Eletriptan—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000278	CcSEcCtD
Eletriptan—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000278	CcSEcCtD
Eletriptan—Vomiting—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000277	CcSEcCtD
Eletriptan—Rash—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000275	CcSEcCtD
Eletriptan—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000275	CcSEcCtD
Eletriptan—Nausea—Metformin—type 2 diabetes mellitus	4.66e-05	0.000275	CcSEcCtD
Eletriptan—Headache—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000273	CcSEcCtD
Eletriptan—Dizziness—Losartan—type 2 diabetes mellitus	4.6e-05	0.000271	CcSEcCtD
Eletriptan—Vomiting—Losartan—type 2 diabetes mellitus	4.43e-05	0.000261	CcSEcCtD
Eletriptan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000259	CcSEcCtD
Eletriptan—Nausea—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000259	CcSEcCtD
Eletriptan—Rash—Losartan—type 2 diabetes mellitus	4.39e-05	0.000259	CcSEcCtD
Eletriptan—Dermatitis—Losartan—type 2 diabetes mellitus	4.39e-05	0.000259	CcSEcCtD
Eletriptan—Headache—Losartan—type 2 diabetes mellitus	4.36e-05	0.000257	CcSEcCtD
Eletriptan—Asthenia—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000253	CcSEcCtD
Eletriptan—Pruritus—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000249	CcSEcCtD
Eletriptan—Nausea—Losartan—type 2 diabetes mellitus	4.13e-05	0.000244	CcSEcCtD
Eletriptan—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000241	CcSEcCtD
Eletriptan—Dizziness—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000233	CcSEcCtD
Eletriptan—Vomiting—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000224	CcSEcCtD
Eletriptan—Rash—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000222	CcSEcCtD
Eletriptan—Dermatitis—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000222	CcSEcCtD
Eletriptan—Headache—Ramipril—type 2 diabetes mellitus	3.74e-05	0.00022	CcSEcCtD
Eletriptan—Nausea—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000209	CcSEcCtD
Eletriptan—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.66e-06	3.92e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.65e-06	3.91e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.65e-06	3.91e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.63e-06	3.9e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.62e-06	3.88e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.62e-06	3.88e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.61e-06	3.87e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RELA—type 2 diabetes mellitus	3.57e-06	3.83e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	3.57e-06	3.83e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.56e-06	3.82e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RELA—type 2 diabetes mellitus	3.55e-06	3.81e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.55e-06	3.81e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.54e-06	3.8e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.53e-06	3.78e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.51e-06	3.76e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	3.5e-06	3.76e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.5e-06	3.75e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.5e-06	3.75e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	3.48e-06	3.73e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.47e-06	3.72e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.47e-06	3.72e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.47e-06	3.72e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.47e-06	3.72e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	3.4e-06	3.65e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.35e-06	3.59e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.3e-06	3.54e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.28e-06	3.52e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.28e-06	3.52e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RELA—type 2 diabetes mellitus	3.27e-06	3.5e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.26e-06	3.5e-05	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.25e-06	3.49e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.25e-06	3.49e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	3.25e-06	3.49e-05	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.23e-06	3.47e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.22e-06	3.46e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.22e-06	3.45e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	3.21e-06	3.45e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	3.21e-06	3.44e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.2e-06	3.44e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.2e-06	3.44e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.2e-06	3.43e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.2e-06	3.43e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.18e-06	3.42e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.18e-06	3.41e-05	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.17e-06	3.4e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.16e-06	3.39e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.14e-06	3.37e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.14e-06	3.36e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.13e-06	3.35e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.12e-06	3.34e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.1e-06	3.33e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.1e-06	3.33e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.09e-06	3.31e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.08e-06	3.3e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.07e-06	3.3e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	3.07e-06	3.3e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.05e-06	3.27e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.05e-06	3.27e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.04e-06	3.26e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.03e-06	3.25e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.02e-06	3.24e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.02e-06	3.24e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.01e-06	3.23e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.01e-06	3.23e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.01e-06	3.23e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3e-06	3.22e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.99e-06	3.21e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.99e-06	3.21e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.99e-06	3.21e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.98e-06	3.2e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.97e-06	3.19e-05	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.97e-06	3.19e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	2.97e-06	3.19e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.97e-06	3.18e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.96e-06	3.18e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.96e-06	3.18e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.96e-06	3.17e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.95e-06	3.17e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.95e-06	3.16e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.95e-06	3.16e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.94e-06	3.15e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.94e-06	3.15e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.94e-06	3.15e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—type 2 diabetes mellitus	2.94e-06	3.15e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.94e-06	3.15e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.94e-06	3.15e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.93e-06	3.15e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.93e-06	3.14e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.92e-06	3.14e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.92e-06	3.13e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.91e-06	3.12e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.91e-06	3.12e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.87e-06	3.08e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.87e-06	3.08e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.87e-06	3.08e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.85e-06	3.06e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.85e-06	3.06e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.84e-06	3.05e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.84e-06	3.04e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.84e-06	3.04e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.81e-06	3.02e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.81e-06	3.02e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	2.81e-06	3.02e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SRC—type 2 diabetes mellitus	2.81e-06	3.01e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.8e-06	3e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.8e-06	3e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	2.79e-06	2.99e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.78e-06	2.99e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—type 2 diabetes mellitus	2.77e-06	2.97e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.77e-06	2.97e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.77e-06	2.97e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.75e-06	2.95e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.74e-06	2.94e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.74e-06	2.93e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.73e-06	2.93e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.73e-06	2.93e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.72e-06	2.92e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.72e-06	2.92e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.71e-06	2.91e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.7e-06	2.9e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.69e-06	2.88e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.69e-06	2.88e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.68e-06	2.87e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.66e-06	2.86e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.66e-06	2.85e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.65e-06	2.85e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.65e-06	2.84e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.64e-06	2.83e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.64e-06	2.83e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.64e-06	2.83e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.64e-06	2.83e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.62e-06	2.81e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.61e-06	2.8e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.59e-06	2.78e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.59e-06	2.77e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.58e-06	2.76e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.57e-06	2.76e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.57e-06	2.75e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.57e-06	2.75e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.56e-06	2.74e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.55e-06	2.74e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.55e-06	2.74e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.51e-06	2.69e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.51e-06	2.69e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.51e-06	2.69e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.5e-06	2.68e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.5e-06	2.68e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.49e-06	2.68e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.49e-06	2.67e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.47e-06	2.65e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.47e-06	2.65e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.46e-06	2.64e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.45e-06	2.63e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.45e-06	2.63e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.45e-06	2.62e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.44e-06	2.62e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.44e-06	2.62e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.42e-06	2.6e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.41e-06	2.59e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.41e-06	2.59e-05	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.41e-06	2.59e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.4e-06	2.58e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.39e-06	2.57e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.39e-06	2.56e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.39e-06	2.56e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.39e-06	2.56e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.37e-06	2.55e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.35e-06	2.52e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.33e-06	2.5e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.31e-06	2.48e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.3e-06	2.47e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.29e-06	2.46e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.29e-06	2.46e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.29e-06	2.45e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.29e-06	2.45e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.28e-06	2.45e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.27e-06	2.44e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.26e-06	2.42e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.25e-06	2.42e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.25e-06	2.41e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.23e-06	2.4e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.19e-06	2.35e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.18e-06	2.34e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.14e-06	2.29e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.13e-06	2.28e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.09e-06	2.24e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.08e-06	2.23e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.03e-06	2.17e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2e-06	2.15e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.99e-06	2.13e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.97e-06	2.11e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.97e-06	2.11e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.97e-06	2.11e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.96e-06	2.1e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.96e-06	2.1e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.95e-06	2.09e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.94e-06	2.08e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.91e-06	2.05e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	1.89e-06	2.03e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.88e-06	2.02e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.88e-06	2.02e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.87e-06	2.01e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.87e-06	2.01e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.86e-06	2e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.84e-06	1.97e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.83e-06	1.96e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.83e-06	1.96e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.83e-06	1.96e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.82e-06	1.96e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.8e-06	1.93e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.79e-06	1.93e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.79e-06	1.92e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.76e-06	1.88e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.75e-06	1.88e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.75e-06	1.87e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.73e-06	1.86e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.73e-06	1.85e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.72e-06	1.85e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.72e-06	1.85e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.71e-06	1.84e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.71e-06	1.83e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.71e-06	1.83e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.71e-06	1.83e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.7e-06	1.82e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.68e-06	1.81e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.67e-06	1.79e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.62e-06	1.73e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.6e-06	1.71e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.59e-06	1.7e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.58e-06	1.69e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-06	1.68e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.54e-06	1.65e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.51e-06	1.62e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.5e-06	1.61e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	1.49e-06	1.6e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.49e-06	1.6e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.41e-06	1.52e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.4e-06	1.5e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.31e-06	1.41e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.29e-06	1.39e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.29e-06	1.38e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.18e-06	1.26e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.13e-06	1.21e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.13e-06	1.21e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	1.11e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.61e-07	9.24e-06	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	8.41e-07	9.02e-06	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.92e-07	8.5e-06	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.85e-07	8.43e-06	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.18e-07	5.56e-06	CbGpPWpGaD
